HOME >> BIOLOGY >> NEWS
Tufts researchers identify a novel target for cancer therapy

Who: Daniel Jay, PhD, Brenda K. Eustace, Takashi Sakurai, Jean K. Stewart, Dean Yimlamai - Department of Physiology, Tufts University School of Medicine, Boston, MA

What: Tufts University researchers and colleagues have discovered an extracellular form of heat shock protein 90 (hsp90) and shown its role in cancer invasion.

Where: Published in Nature Cell Biology Volume 6, 2004

When: June, 2004

Why: Invasion is a key step in tumor progression that eventually leads to metastases when a disseminated tumor cell penetrates through the extracellular matrix and establishes a secondary tumor site elsewhere.

To date there are no effective and safe treatments against metastases due to the lack of reliable validated drug targets. Hsp90 recently has gained significant attention as an important target for cancer therapeutics and hsp90 inhibitors are currently in Phase I and II clinical trials. Since hsp90 is also a key protein for normal cell function, there is some concern about treatment-related toxicity, especially if hsp90 inhibitors are unable to distinguish normal and cancer cells.

In the published article entitled "Functional Proteomic Screens Reveal an Essential Extracellular Role for Hsp90a in Cancer Cell Invasiveness," the researchers used a functional screen on the cell surface proteome of a highly invasive human tumor cell line. The screen identified the extracellular hsp90 associated with tumor cell invasion.

The researchers demonstrated a direct physical and functional interaction between hsp90 and matrix metalloproteinase 2 (MMP2), a primary player in the tumor invasion process. This opens the possibility for developing antibodies against hsp90 for the treatment of cancer.

"This work highlights the relevance of validating function at the protein level. Genetic approaches would have missed the discovery of the novel mechanism of hsp90 action" said Daniel Jay,
'"/>

Contact: Peggy Hayes
peggy.hayes@tufts.edu
617-636-3707
Tufts University
1-Jun-2004


Page: 1 2

Related biology news :

1. Tufts University establishes $4 million dollar tissue engineering resource center
2. Study by Tufts biologist provides window into progression of some degenerative diseases
3. Tufts University groundbreaking research on caterpillar locomotion
4. Research news from Tufts University, Friedman School of Nutrition Science and Policy: February 2004
5. Highlights of Tufts University nutrition research: January 2004
6. Tufts University wins $25-million NIH contract
7. Tufts scientist named one of worlds 100 top young innovators by Technology Review Magazine
8. Tufts University bioengineers discover secret of spider, silkworm fiber strength
9. Tufts researchers find new cost-effective catalyst for hydrogen production for fuel cells
10. Tufts University biologists unveil more mysteries of fireflies flash
11. Tufts environmental engineers tackle destructive nutrients in nations waterways

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, ... industry and the third highest quality portfolio following Seres Health and Nestle, as ... Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and ...
(Date:3/14/2019)... , ... March 13, 2019 , ... Bode Technology (Bode), a leading provider ... on more than 100,000 sexual assault kits. As thousands of untested kits are identified ... sexual assault kit backlogs . Bode has tested more than 50,000 kits in the ...
(Date:3/12/2019)... SANTA CLARA, Calif. (PRWEB) , ... March 12, ... ... world leader in strong multi-factor authentication and combined technology all-in-one smart cards, announced ... combined with FIDO strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... WHITEHOUSE, N.J. (PRWEB) , ... March 19, 2019 , ... ... and is a great opportunity to see the most cutting-edge cancer research. The Visikol ... work with 3D cell culture assays as well as their digital ...
(Date:3/19/2019)... ... ... will review strategies for data management in modular and adaptive clinical trials. , Participants will:, ... 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster , ... reducing risk and impact on trial success, trial teams, and trial execution , ...
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... DESERT, Calif. (PRWEB) , ... March 14, 2019 ... ... issued a press release announcing that its Canadian partner, the Eye Machine Canada ... Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , ...
Breaking Biology Technology:
Cached News: